• Aucun résultat trouvé

WHO WHO

N/A
N/A
Protected

Academic year: 2022

Partager "WHO WHO"

Copied!
7
0
0

Texte intégral

(1)

One volume of the Bulletin ofthe World Health Organization is published each year.

Annual subscription (1998) Vol. 76(6numbers) Sw.fr. 194- Pricepernumber Sw.fr. 42-

(Prices include handling and despatch bysurfacemail.) Specialratesfor subscriptions to all or variousWHO publications, including the Bulletin are quoted in the catalogue of WHO publications, which is obtainable free of charge fromthe World Health Organization, Distribution and Sales, 1211 Geneva 27, Switzerland.

Directions to contributors are published twice in each volume of the Bulletin- inEnglish in No. 1 andin French in No. 6. Pro- spective contributors may also obtain copies on request to the Editor, Bulletin ofthe WorldHealthOrganization, 1211 Geneva27, Switzerland.

Un volume du Bulletin del'Organisation mondiale delaSanteparait chaqueannee.

Abonnement annuel (1998) Vol.76(6numeros) Fr.s. 194.

Lenumero Fr.s. 42-

(Lesprixindiquescomprennentlesfrais d'envoiparsurface.) Des prix speciaux pour I'abonnementa 1'ensemble des publica- tions deI'OMSou a certaines d'entreelles, comprenant leBulletin, figurentdanslecatalogue despublicationsdel'OMS,quipeutetre obtenugratuitement aupres del'Organisation mondiale delaSante, Service de DistributionetVente, 1211Geneve27, Suisse.

Les Directives pour les auteurs sont publiees en anglais dans le numero 1 et en francais dans le numero 6 de chaque volume du Bulletin. Les personnes interessees peuvent egalement en obtenir un exemplaire surdemande adressee au Redacteur en Chef du Bulletin de l'Organisation mondiale de la Sante, 1211 Geneve 27, Suisse.

(2)

SUPPLEMENT No 1 TO VOLUME 75, 1997, OF THE

BULLEFTIN

OF THE WORLD HEALTH ORGANIZATION DE L'ORGANISATION MONDIALE DE LA SANTE

THE SCIENTIFIC JOURNAL OF WHO*LA REVUE SCIENTIFIQUE DE L'OMS

INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS:

A WHO/UNICEF INITIATIVE

WORLD HEALTH ORGANIZATION, GENEVA * ORGANISATION MONDIALE DE LA

SANTE,

GENEVE

_

(3)

© Organisation mondiale de laSante 1997

PublicationsoftheWorld HealthOrganizationenjoy copyright protectioninaccordancewith theprovisionsof Protocol2ofthe Universal Copyright Convention.

Forrights ofreproduction or translationof WHOpublications, in part or in toto, application should be made to theOffice of Publications, World Health Organization, 1211 Geneva 27, Switzerland. The World Health Organization welcomes such applications.

Authors alone areresponsible forviewsexpressed insigned articles.

Thedesignations employedand the presentationofthematerial inthis publication do not imply the expression of any opinion whatsoeveron thepartof theSecretariatof the World Health Organization concerning thelegalstatusofany country, terri- tory, city, or area or of itsauthorities,orconcerningthedelimi- tationofitsfrontiersorboundaries.

Thementionofspecificcompanies or of certainmanufacturers' products does not imply that they are endorsed or recom- mended by the World Health Organization in preference to othersofasimilarnaturewhichare notmentioned. Errors and omissions excepted, the names of proprietary products are distinguishedby initialcapital letters.

Les publications de l'Organisation mondiale de la Sante beneficient de la protection prevue par les dispositions du ProtocoleNO 2 de la Conventionuniverselle pourla Protection du Droit d'Auteur.

Pourtoute reproductionoutraductionpartielle ouintegrale,une autorisation doit etre demandee au Bureau des Publications, Organisation mondiale de laSante, 1211 Geneve27, Suisse.

L'Organisation mondiale de la Sante sera toujours tres heureuse de recevoir desdemandes a ceteffet.

Lesarticlessignesn'engagent que les auteurs.

Les appellations employees dans cette publication et la presentationdesdonneesqui yfigurentn'impliquent delapart duSecretariat del'Organisation mondialede laSanteaucune prise de positionquantau statutjuridiquedespays,territoires, villesou zones, oude leurs autorites,ni quant autrace deleurs frontieresou limites.

La mentiondefirmeset de produitscommerciaux n'implique pas que cesfirmesetproduits commerciauxsontagrees ou recommandes par l'Organisation mondiale de la Sante de preferencead'autres. Sauf erreur ou omission, une majuscule initiale indique qu'ils'agitd'un nomdepose.

ISBN 9240687505 TypesetinHongKong

Printed inFinland

96/11207 -BestSet/Vammala- 5500 . World HealthOrganization1997

(4)

SUPPLEMENTNO. TOVOLUME 75, 1997, OF THE

BULETIN

OF THE WORLD HEALTH ORGANIZATION DE L'ORGANISATIONMONDIALE DE LA SANTE

INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS:

A WHO/UNICEF INITIATIVE

Integrated Management of Childhood Illness (IMCI) is a strategy that aims to reduce child deaths and the frequency and severity

of illness and disability among children in developing countries, and to contribute to improved growth and development. The strategy addresses the five major life-threatening conditions of childhood: acute respiratory infections (ARI), diarrhoea, mea- sles, malaria and malnutrition. It includes activities designed to improve the performance of health workers, to improve health systems, and to improve family and community practices. The core of the MCI strategy, and the first intervention made available to countries, is the application of clinical guidelines for integrated case management at first-level health facilities.

These guidelines were developed based on existing scientific evidence, on formal evaluations of their effectiveness in selected developing country settings, and on specially designed studies to address remaining questions about the most appropriate clinical signs to be used in assessing specific illnesses. The refined clinical guidelines were then used as the basis for the development and field testing of a training course for health workers who manage children in first-level health facilities. The IMCI guidelines and training course are adapted to the specific epidemiological and other ocal conditions in individua coun- tries, and have served as a starting point for broader IMCI

planning and implementation in nearly 40 countries since 1 996.

Price: Sw fr. 20.-

Price in developingcountries: Sw fr. 14- ISBN 92 4 068750 5

(5)

CONTENTS

Preface ..5

Integrated management ofchildhood illnessby outpatient healthworkers: technical basis and overview-S. Covefor the WHO WorkingGrouipon GutidelinesforIntegrated Management of

theSick Child ...7... ... ... 7 Evaluationofanalgorithm for the integrated managementofchildhood illnessinan areawith

seasonal malaria inthe Gambia-M.W. Weber, E.K. Mulholland, S.Jaffar, H. Troedsson, S. Cove,

& B.M. Greenwood. ... 25

Evaluation ofanalgorithm forintegrated managementofchildhoodillness inan area ofKenya with high malariatransmission-B.A. Perkins.JR. Zuicker,J. Otieno, H.S.Jafari, L. Paxton, S.C. Redd, B.L. Nahlen, B. Schwartz, A.J. Oloo, C. Olango, S. Gove, & C.C. Canmpbell .33

Performance ofhealth workers after trainingin integrated management ofchildhoodillnessin Gondar, Ethiopia-E.A.F. Sinmoes T Desta, T. Tessenma, T. Gerbresellassie, MI. Dagnew, & S. Gove .43 Integratedmanagement ofchildhood illness: fieldtest ofthe WHO/UNICEFtraining course in Arusha,

United Republic of Tanzania-WHO Divisionof Child Health andDevelopnment& WHO Regional Office for Africa ... ... ... 55 Identifying sick children requiringreferral tohospital in Bangladesh-H.D. Kalter, J.A. Schillinger,

M. Hossain, G. Blurnhanm, S. Saha, V. de Wit, N.Z. Khan, B. Schwartz, & R.E. Black .65 Theintegrated management of childhoodillness in western Uganda-P.R. Kolstad, G. Bulrnham,

H.D. Kalter, N. Kenva-Mulgisha, & R.E. Black... ... ... 77 Assessmentofpotential indicatorsforprotein-energy malnutritionin thealgorithm for integrated

management ofchildhood illness-C. Bern,J.R. Zlucker, B.A. Perkins, J. Otieno, A.J. Oloo,

& R. Yip ... ... ...7... 87 Clinical signsforthe recognition of children with moderate or severeanaemia inwesternKenya-

J.R. Zlucker, B.A. Perkins, H.Jafari, J. Otieno, C. Obonvo, & C.C. Capbell.97

Evaluation ofclinicalsignstodiagnose anaemiain Uganda and Bangladesh, in areaswith and without malaria-H.D. Kalter, G. Bulrnhanm, P.R. Kolstad, M. Hossain,J.A. Schillinger, N.Z. Khan, S. Saha, V. de Wit, N. Kenya-Mugisha, B. Schwartz, & R.E. Black ... ... ... 103 Pallor as aclinical signofsevere anaemiainchildren: aninvestigation in the Gambia-M.W. Weber,

S.D. Kellingray, A. Palmer, S. Jaffor, E.K. Mlulholland, & B.M. Greenwood.113 Integrated management ofchildhood illness: conclusions-WHO Division of ChildHealth

andDevelopment... ... ... ... 119

WHO BulletinOMS. Vol75. Suppl.1. 1997

(6)

PREFACE

Every year more than 11 millionchildren in developing countries die beforethey reach theirfifth birthday, manyduring thefirstyearoflife. Seven in tenofthesedeaths aredueto acute respiratoryinfections (mostly pneumonia), diarrhoea, measles, malaria ormalnutrition-and often to a combination ofthese conditions.

Much has been learned fromdisease-specific child survivalprogrammes inthepast 15 years.The challenge now is to apply the lessons from these programmes to strategies that promote coordination and, where appropriate,greaterintegration of activitiesinordertoimprove the prevention and managementof childhood illness. The WHO Division of Child Health and Development (CHD), in collaboration with ten otherWHO programmes, UNICEF,theWorld Bankand numerous other agencies andinstitutions, hasrespondedtothis challenge by developing the Integrated Management of Childhood Illness (IMCI) strategy.

Usingasetof interventions for the integratedtreatmentand prevention of major childhoodillnesses, the IMCI strategy aimsto reduce death andthefrequencyandseverity of illnessanddisability, andtocontribute to improved growth and development. This set of interventions aims to improve practices both in health facilitiesand in the home.

The coreofthe IMCI strategy, and the firstintervention to bemade available tocountries, is a setof guidelines forintegrated casemanagementof the five mostimportantcausesof childhood deaths-acute respiratory infections (ARI), diarrhoea, measles, malaria and malnutrition - and of common associated conditions, inoutpatientsettings. This supplementtothe Bulletin of the World HealthOrganization provides the technical basis for the IMCI case management guidelines, and reports on the development and field testing of the WHO/UNICEF IMCI training course forfirst-level health workers.

In individual countries, the combination of clinical guidelines that constitute IMCI may be modified to include other important conditions for which effective treatment and/or preventive practices have been identified. The main interventions of the global IMCI strategy will evolve as experience is gained in implementation andas newfindings from health research become available.

IMCI hasprovided a newimpetus foreffortsto promote childhealthanddevelopment. Theresponse to IMCI onthepartofMinistries of Health has beenfargreaterthan expected inthe 20 monthssince the first guidelines and training course became available. As of September 1997, 39 countries in the developing world had committed themselves to moving forward with IMCI, and discussions had started in seven additional countries.Agencies and institutions committedtoimproving child health have providedsupportfor IMCI at country, regional and global levels, and are undertaking significant research and development efforts. As the momentum for the IMCI strategy builds, the importance of generating and disseminating scientific evidenceon theefficacy and effectiveness ofspecific IMCI interventions increases. This volume seekstocontributeto acontinuing scientific dialogue about IMCI and its potential for improving child health anddevelopment.

WHO Bulletin OMS. Vol75,Suppl.1, 1997

(7)

PREFACE

Chaqueann6e, plusde 11 millions d'enfants despays end6veloppementmeurent avant d'avoir atteint leur cinquieme anniversaire, etbeaucoup d'entre eux pendant leur premiereann6e. Sur dixde ces d6ces,sept sont imputables aux infections respiratoires aigues (pneumonie essentiellement), a la diarrh6e, a la rougeole, au paludisme ou a la malnutrition - et souventa une association de ces pathologies. Ces 15 dernieres ann6es les programmes de survie de 1'enfant visant des maladies specifiques ont et6 riches d'enseignements. 11convient maintenantd'appliquerlesle9ons tireesde ces programmes auxstrat6giesqui favorisent lacoordination, ets'il y alieu laplus grande int6grationdes activit6s, demaniere aam6liorerla prevention et la prise en charge desmaladiesdel'enfant. LaDivision de laSant6etduD6veloppement de l'Enfant (CHD), encollaboration avec dix autres programmes de l'OMS, l'UNICEF, la Banque mondiale et des agences et organismes nombreux etvari6s, a repondu en elaborant la strategie de prise en charge integree desmaladies de 1'enfant (IMCI).

S'appuyantsur un ensemble coh6rentd'interventionspour parvenir aun traitement et uneprevention int6gr6s des grandes maladies de 1'enfant, I'IMCI vise a r6duire tant la mortalite que la fr6quence et la gravit6de lamaladieetde l'incapacit6,etaam6liorer lacroissance etled6veloppement. Ces interventions ontpourbutd'am6liorer les pratiquesau centre desant6 comme au domicile.

Le fondement de l'IMCI, et lapremiere intervention a mettrea ladisposition despays, est un groupe de recommandationspour lapriseenchargeint6gr6e des cinq plus importantescausesded6ces de l'enfant

-infections respiratoires aigues (ARI), diarrhee, rougeole, paludisme et malnutrition-et despathologies courantes associ6es, dans le cadre ambulatoire. Le pr6sent suppl6ment du Bulletin de l'Organisation mondialede laSant6fournit les basestechniques des recommandations pour la prise encharge dans le cadrede l'IMCI, etrend comptede la miseaupointetde l'essaisur leterrain du coursde formation OMS/

UNICEF a l'IMCI destine auxagents de sant6de premier niveau.

Les recommandations cliniques dont le corps forme l'IMCI peuvent etre modifi6es par un pays, pour inclure d'autres affections importantes pourlesquellesexistent untraitementetlouunepr6ventionefficaces.

Les principales interventionsdel'IMCI al'echelle mondiale evoluerontpour tenir compte del'experience tir6e de sa miseen ceuvreetdesdecouvertes de la recherche ensant6.

L'IMCIa donne un nouvel 6lan auxactionsde promotion de lasanteetdu d6veloppementdel'enfant.

Dans les 20 mois qui ont suivi la mise a disposition des premieres recommandations et du cours de formation, la r6ponsedes ministeres de la sant6vis-a-vis de l'IMCI ad6pass6 lesattentes. Enseptembre 1997, 39 pays du monde endeveloppement s'6taient engages en faveur del'IMCI et sept autresavaient entam6des discussions. Lesagences etles institutionsquiconsacrentleursactivit6sal'am6liorationde la sant6de l'enfantont apport6leur soutien a l'IMCI au niveau du pays, de la region etde laplanete, et ont entrepris des efforts de recherche et de d6veloppement importants. La strat6gie de l'IMCI prenant une importance croissante, il importe de plusenplus defourniretdefaireconnaitrelesargumentsscientifiques quiattestentl'utilit6etl'efficacite des interventionssp6cifiquesdecettestrat6gie.Ce volumeapourobjet de contribuer a la poursuite du dialogue scientifique sur l'IMCI et sa capacite a am6liorer la sante et le d6veloppement de l'enfant.

WHO BulletinOMS. Vol75,Suppl.1, 1997 6

Références

Documents relatifs

developing and implementing national health technology policies and programmes within the broad health systems and service delivery context, including feedback on use of

This publication contains the report of the Second Meeting of the WHO Technical Advisory Group on Health Technology and does not necessarily represent the decisions or policies of

1. To approve the programme on Maternal and Child Health, submitted by the Interim Commission of the WHO. To regard the following measures arising out of the proposals of the

sanitation, maternal and child care, immunization, health education, prevention and treatment of common local diseases, and provision of essential drugs. Wherever this much

BP-4 Information, education and communication* interventions regarding FGM and women’s health should be provided to girls and women living with any type of FGM (Best

Providing information to improve body image and care-seeking behaviour of women and girls living with female genital mutilation.. 2015

NOTES the report of the Director-General on the situation regarding the possibilities for the acceptance of amendments to the Constitution of the World

A cross-sectional study was conducted to determine by laboratory confirmation the prevalence of Neisseria gonorrhoea, Chlamydia trachoma tis, Trichomonas vaginalis,